Literature DB >> 15474102

Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women.

Artur J Jakimiuk1, Michal Bogusiewicz, Rafal Tarkowski, Piotr Dziduch, Aneta Adamiak, Andrzej Wróbel, Józef Haczyński, Denis A Magoffin, Jerzy A Jakowicki.   

Abstract

OBJECTIVE: To measure messenger RNA levels of estrogen receptor (ER) alpha and beta in uterine leiomyomas, normal myometrium, and endometrium.
DESIGN: Prospective study.
SETTING: University hospital. PATIENT(S): Seventeen premenopausal women who underwent surgery due to symptomatic uterine leiomyomas. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Quantitative RT-PCR was used for evaluation of ERalpha and ERbeta expression. Results were normalized to total cellular DNA. RESULT(S): Expression of ERalpha and ERbeta did not differ between leiomyomas and myometrium; however, in both tissues, expression of ERalpha was significantly higher than that of ERbeta. Estrogen receptor-alpha expression in endometrium was lower than in leiomyomas and myometrium. In leiomyomas and endometrium, correlations between expression of ERalpha and ERbeta were found. CONCLUSION(S): Uterine leiomyomas, myometrium, and endometrium display distinct patterns of ER expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474102     DOI: 10.1016/j.fertnstert.2004.02.130

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

Review 2.  Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.

Authors:  Molly B Moravek; Serdar E Bulun
Journal:  Curr Opin Obstet Gynecol       Date:  2015-08       Impact factor: 1.927

3.  Association of polymorphisms and haplotypes in the cytochrome P450 1B1 gene with uterine leiomyoma: A case control study.

Authors:  Saeedeh Salimi; Maryam Khodamian; Mehrnaz Narooie-Nejad; Azam Hajizadeh; Kimia Fazeli; Lida Namazi; Minoo Yaghmaei
Journal:  Biomed Rep       Date:  2014-12-31

4.  Involvement of Bcl-2, Src, and ERα in gossypol-mediated growth inhibition and apoptosis in human uterine leiomyoma and myometrial cells.

Authors:  Yan ZHU; Shu-wu XIE; Jian-feng ZHANG; Ting-ting ZHANG; Jie-yun ZHOU; Yang CAO; Lin CAO
Journal:  Acta Pharmacol Sin       Date:  2010-11-22       Impact factor: 6.150

Review 5.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

6.  CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.

Authors:  Yi Ye; Xiao Cheng; Hai-Bo Luo; Li Liu; Ying-Bi Li; Yi-Ping Hou
Journal:  J Assist Reprod Genet       Date:  2008-09-02       Impact factor: 3.412

7.  G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.

Authors:  Burcu Kasap; Nilgün Öztürk Turhan; Tuba Edgünlü; Müzeyyen Duran; Eren Akbaba; Gökalp Öner
Journal:  Bosn J Basic Med Sci       Date:  2016-01-06       Impact factor: 3.363

8.  A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells.

Authors:  X Di; L Yu; A B Moore; L Castro; X Zheng; T Hermon; D Dixon
Journal:  Hum Reprod       Date:  2008-05-20       Impact factor: 6.918

Review 9.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

Authors:  Molly B Moravek; Ping Yin; Masanori Ono; John S Coon; Matthew T Dyson; Antonia Navarro; Erica E Marsh; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2014-09-08       Impact factor: 15.610

10.  Large, Non-Cavity Distorting Intramural Leiomyomas Decrease Leukemia Inhibitory Factor in the Secretory Phase Endometrium.

Authors:  Bruce Pier; Christopher Crellin; Ashwini Katre; Michael G Conner; Lea Novak; Steven L Young; Rebecca Arend
Journal:  Reprod Sci       Date:  2020-01-01       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.